The Washington Global Health Alliance, a group representing 26 life-sciences businesses, institutions and governmental organizations, has completed an internal coordination study demonstrating the significant influence of its primary partners in the mission of global health.
Examining the current projects conducted by nine of 11 executive member institutions on the WGHA board, the study reveals that members collectively and directly run 480 health projects in 92 countries, including the United States. With those projects, members work with 593 unique partners, including 44 foreign government entities.
"This demonstrates in hard, quantitative terms the unique spirit of collaboration that infuses our character here in the Northwest," said Lisa Cohen, director of the Washington Global Health Alliance. "We hope this research captures the passion that our members have for eradicating disease and improving the lives of millions of people around the world."
Battelle/Pacific Northwest National Laboratories, the Fred Hutchinson Cancer Research Center, the Infectious Disease Research Institute, the Institute for Systems Biology, PATH, Seattle Biomedical Research Institute (SBRI), Seattle Children's Hospital and Research Institute, including its Global Alliance for the Prevention of Prematurity and Stillbirth (GAPPS) program, the University of Washington and Washington State University participated in the study, which was conducted by Berk & Associates of Seattle.
The first-of-its-kind study will be introduced at 4 p.m. today (Wednesday, Nov. 18) at the first of four sessions in the Domesticating Global Health Series at SBRI presented by the Washington Biotechnology & Biomedical Association (WBBA). The WBBA is an independent, nonprofit 501(c)(6), trade association serving the life sciences industry in the state of Washington.